Simvastatin has been reported to inhibit AAA formation induced by angiotensin II (AngII) in apolipoprotein E knockout (Apoe−/−) mice [24–26], while rosuvastatin and atorvastatin had no benefit for abdominal aortic aneurysms [27]. Here, APOE is linked to triple-A syndrome.